724 related articles for article (PubMed ID: 18854757)
1. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of inflammatory markers in hypertensives with target organ damage.
Jastrzebski M; Czarnecka D; Rajzer M; Kawecka-Jaszcz K
Kardiol Pol; 2006 Aug; 64(8):802-9; discussion 810-1. PubMed ID: 16981055
[TBL] [Abstract][Full Text] [Related]
3. Relationship between inflammation and microalbuminuria in prehypertension.
Navarro-González JF; Mora C; Muros M; García J; Donate J; Cazaña V
J Hum Hypertens; 2013 Feb; 27(2):119-25. PubMed ID: 22277919
[TBL] [Abstract][Full Text] [Related]
4. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
5. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
Sciarretta S; Ferrucci A; Ciavarella GM; De Paolis P; Venturelli V; Tocci G; De Biase L; Rubattu S; Volpe M
Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
[TBL] [Abstract][Full Text] [Related]
6. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
7. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
[TBL] [Abstract][Full Text] [Related]
8. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension.
Cottone S; Mulè G; Nardi E; Vadalà A; Guarneri M; Briolotta C; Arsena R; Palermo A; Riccobene R; Cerasola G
Am J Hypertens; 2006 Mar; 19(3):313-8. PubMed ID: 16500520
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, interleukin-6, and tumor necrosis factor-alpha levels in overweight and healthy adults.
Chaikate S; Harnroongroj T; Chantaranipapong Y; Puduang S; Mahaisiriyodom A; Viroonudomphol D; Singhasivanon P; Schelp FP; Tornee S; Tribunyatkul S; Changbumrung S
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):374-81. PubMed ID: 17125002
[TBL] [Abstract][Full Text] [Related]
11. Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage.
Yu X; Yang Z; Yu M
Ren Fail; 2010 May; 32(4):475-9. PubMed ID: 20446787
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 microglobulin as a new inflammatory marker in newly diagnosed hypertensive patients.
Vyssoulis GP; Tousoulis D; Antoniades C; Dimitrakopoulos S; Zervoudaki A; Stefanadis C
Am J Hypertens; 2007 Sep; 20(9):1016-21. PubMed ID: 17765145
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
[TBL] [Abstract][Full Text] [Related]
14. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension.
Tsioufis C; Stougiannos P; Kakkavas A; Toutouza M; Mariolis A; Vlasseros I; Stefanadis C; Kallikazaros I
Am J Cardiol; 2005 Jul; 96(2):252-6. PubMed ID: 16018852
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure.
Cuspidi C; Valerio C; Sala C; Esposito A; Masaidi M; Negri F; Zanchetti A; Mancia G
Blood Press Monit; 2008 Feb; 13(1):7-13. PubMed ID: 18199918
[TBL] [Abstract][Full Text] [Related]
16. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension.
Bautista LE; Vera LM; Arenas IA; Gamarra G
J Hum Hypertens; 2005 Feb; 19(2):149-54. PubMed ID: 15361891
[TBL] [Abstract][Full Text] [Related]
17. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease.
Mahmud N; O'Connell MA; Stinson J; Goggins MG; Weir DG; Kelleher D
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):215-9. PubMed ID: 7743302
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
[TBL] [Abstract][Full Text] [Related]
20. Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals.
Erden M; Kocaman SA; Poyraz F; Topal S; Sahinarslan A; Boyacı B; Cengel A; Yalçın MR
Turk Kardiyol Dern Ars; 2011 Oct; 39(7):531-9. PubMed ID: 21983762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
